Cardiovascular Risk Factor Profiles and Disease in Black Compared to Other Africans with Chronic Kidney Disease

Hon-Chun Hsu1,2, Chanel Robinson1, Angela J Woodiwiss1

  • 1Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Insights

Black patients with chronic kidney disease (CKD) have less atherosclerosis despite higher cardiovascular risk factors. Dialysis patients show fewer cardiovascular events, possibly due to selection bias.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a major concern in chronic kidney disease (CKD).
  • Racial disparities in CVD risk and outcomes exist, particularly among African Americans.
  • Understanding these disparities in CKD patients is crucial for targeted interventions.

Purpose of the Study:

  • To compare cardiovascular risk factors, atherosclerosis, and cardiovascular event rates between black and other African CKD patients.
  • To evaluate the performance of the Framingham score in predicting atherosclerosis in different racial groups within the CKD population.
  • To investigate potential differences in cardiovascular health between predialysis and dialysis CKD patients based on race.

Main Methods:

  • A cohort of 115 predialysis and dialysis patients (46 black, 69 other races) were assessed.
  • Cardiovascular risk factors, aortic/cardiac function, and atherosclerosis extent were evaluated.
  • Multivariable regression models and receiver operator characteristic curve analysis were employed.

Main Results:

  • Black CKD patients had less carotid artery plaque (OR=0.38) despite a higher cardiovascular risk factor burden.
  • The Framingham score effectively identified non-black CKD patients with plaque but not black patients (AUC=0.818 vs. 0.556).
  • Predialysis black patients had higher Framingham scores and adverse risk factors but similar event rates; dialysis black patients had similar risk factors, improved systolic function, and fewer events (OR=0.22).

Conclusions:

  • Black CKD patients exhibit less severe atherosclerosis and weaker risk factor-atherosclerosis relationships compared to other African CKD patients.
  • These disparities may stem from differing epidemiological health transition stages.
  • Reduced cardiovascular events in black dialysis patients may indicate selection bias, mirroring findings in black Americans.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
345
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
296
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
197
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
79
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
136
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
250